Trademark Search  /  ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

● Live · Registered

U.S. federal trademark · Serial No. 87703113 · Reg. No. 6158527

Mark
ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML
Status
Registered
Serial Number
87703113
Registration No.
6158527
Filing Date
November 30, 2017
Registration Date
September 22, 2020
Class(es)
Class 005

Owners

FIDELIS ANIMAL HEALTH, INC.
03 · NORTH BRUNSWICK, NJ, US
FIDELIS PHARMACEUTICALS, INC.
03 · NORTH BRUNSWICK, NJ, US
FIDELIS PHARMACEUTICALS LLC
16 · North Brunswick, NJ, US
FIDELIS PHARMACEUTICALS LLC
16 · North Brunswick, NJ, US
FIDELIS PHARMACEUTICALS LLC
16 · New Rochelle, NY, US

Goods & Services

Pharmaceutical preparations, namely, buprenorphine extended release injectable suspension to provide analgesia for laboratory animals

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.